China's Mindray diversifies into ortho space with Dragonbio
This article was originally published in Clinica
Executive Summary
Mindray Medical has ventured into the orthopaedics space by acquiring a controlling stake in fellow Chinese company Dragonbio Surgical Implant. The move further consolidates Mindray's already dominant position in China's medical device market, and underlines its strategy to diversify into new product sectors.